Metastatic follicular carcinoma associated with hyperthyroidism

Clinical Nuclear Medicine

Volumn 30, Issue 2, 2005, Pages 79-82

  Rosário, Francisco ^a   Marques, Ana Rita ^a   Roque, Lúcia ^a   Rodrigues, Raquel ^a   Ferreira, Teresa C ^a   Limbert, Edward ^a   Sobrinho, Luís ^a   Leite, Valeriano ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Follicular carcinoma; Hyperthyroidism; Radiodine treatment

Indexed keywords

DNA; IODIDE PEROXIDASE; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; MEDRONATE TECHNETIUM TC 99M; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROXINE;

AGED; ARTICLE; ASPIRATION CYTOLOGY; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; CHROMOSOME 14; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DRUG UPTAKE; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HYPERTHYROIDISM; MALE; RADIOISOTOPE THERAPY; RELAPSE; SKELETON; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TUMOR GROWTH;

ADENOCARCINOMA, FOLLICULAR; AGED; BONE NEOPLASMS; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 12244263044     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200502000-00001     Document Type: Article

References (14)

1. Als C, Gedeon P, Rösler H, et al. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab. 2002;87:4122-4127.
2. Krohn K, Paschke R. Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab. 2001;86:3336-3345.
3. Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 1997;82:735-738.
4. Baloch Z, Livolsi VA. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 1997;82:3906-3908.
5. Moniz S, Catarino AL, Marques AR, et al. Clonal origin of nonmedullary thyroid tumours assessed by non-random X-chromosome inactivation. Eur J Endocrinol. 2002;146:27-33.
6. Camacho P, Gordon D, Chiefari E, et al. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid. 2000;10:1009-1012.
7. Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the a chain of Gs and stimulate adenyl cyclase in human pituitary tumours. Nature. 1989;340:692-696.
8. Merril CR, Goldman D, Van Keuren ML. Gel protein silver stain. Methods in Enzymology. 1984;104:441-447.
9. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory; 2001:4-6.
10. Roque L, Rodrigues R, Pinto A, et al. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromos Cancer. 2003;36:292-302.
11. Gross JL, Moraes VI. Thyroid hormone-producing metastases in differentiated thyroid cancer. J Endocrinol Invest. 1996;19:21-24.
12. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
13. Weetman AP, Shepherdley CA, Mansell P, et al. Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. Eur J Endocrinol. 2003;149:443-447.
14. Kim BW, Daniels GH, Harrison BJ, et al. Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab. 2003;88:594-598.